On Invalid Date, Revelation Biosciences (NASDAQ: REVB) reported Q4 2023 earnings per share (EPS) of -$13.43, up 103.06% year over year. Total Revelation Biosciences earnings for the quarter were -$2.20 million. In the same quarter last year, Revelation Biosciences's earnings per share (EPS) was $439.10.
As of Q1 2024, Revelation Biosciences's earnings has grown year over year. Revelation Biosciences's earnings in the past year totalled -$120.25 thousand.
What is REVB's earnings date?
Revelation Biosciences's earnings date is Invalid Date. Add REVB to your watchlist to be reminded of REVB's next earnings announcement.
What was REVB's revenue last quarter?
On Invalid Date, Revelation Biosciences (NASDAQ: REVB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Revelation Biosciences's revenue was $0.00.
What was REVB's revenue growth in the past year?
As of Q1 2024, Revelation Biosciences's revenue has grown null year over year. Revelation Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.